• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,802.90 -607.08
( -0.78%)
Global Indices
Nasdaq
51,585.70 72.15
(0.14%)
Dow Jones
7,521.58 80.48
(1.08%)
Hang Seng
70,971.12 -82.37
(-0.12%)
Nikkei 225
10,357.71 -41.99
(-0.40%)
Forex
USD-INR
94.39 -0.12
(-0.13%)
EUR-INR
108.40 -1.03
(-0.94%)
GBP-INR
125.08 -1.43
(-1.13%)
JPY-INR
0.59 0.00
(-0.50%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.6032787
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
36.55
70.23
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

VK Global Industries reports standalone net profit of Rs 0.17 crore in the March 2026 quarter
May 28,2026
Net profit of VK Global Industries reported to Rs 0.17 crore in the quarter ended March 2026 as against net loss of Rs 0.20 crore during the previous quarter ended March 2025. Sales rose 666.67% to Rs 0.46 crore in the quarter ended March 2026 as against Rs 0.06 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.13 crore in the year ended March 2026 as against net loss of Rs 0.41 crore during the previous year ended March 2025. Sales rose 707.69% to Rs 1.05 crore in the year ended March 2026 as against Rs 0.13 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.460.06 667 1.050.13 708
OPM %43.48-300.00 -22.86-284.62 -
PBDT0.20-0.18 LP 0.24-0.37 LP
PBT0.17-0.20 LP 0.13-0.41 LP
NP0.17-0.20 LP 0.13-0.41 LP